PRESS RELEASE published on 10/01/2024 at 07:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
BRIEF published on 05/15/2024 at 09:07, 1 year 10 months ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
BRIEF published on 05/15/2024 at 09:07, 1 year 10 months ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
PRESS RELEASE published on 05/15/2024 at 09:02, 1 year 10 months ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 1 year 10 months ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
BRIEF published on 05/15/2024 at 08:06, 1 year 10 months ago Advicenne lance un programme de rachat d'actions Marché Financier Rachat D'actions Euronext Growth Advicenne Maladies Rénales
PRESS RELEASE published on 05/15/2024 at 08:01, 1 year 10 months ago Informations privilégiées / Autres communiqués Advicenne annonce un programme de rachat d'actions autorisé par son assemblée générale mixte. Le programme permet l'achat de jusqu'à 10% du capital social avec un prix maximum de 21 euros par action Rachat D'actions Euronext Growth Programme Autorisation Advicenne
Published on 03/29/2026 at 12:15, 17 hours 8 minutes ago China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 2 days 4 hours ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 2 days 4 hours ago Notification of Relevant Change to Significant Shareholder
Published on 03/29/2026 at 17:05, 12 hours 17 minutes ago FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
Published on 03/28/2026 at 10:05, 1 day 19 hours ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 20 hours ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 2 days 3 hours ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 2 days 7 hours ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 19:06, 2 days 10 hours ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 2 days 10 hours ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 2 days 10 hours ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
